{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:03:30Z","timestamp":1793955810986,"version":"4.8.0"},"reference-count":142,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ejmech.2021.113278","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:12:57Z","timestamp":1613434377000},"page":"113278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":90,"special_numbering":"C","title":["A review on ferulic acid and analogs based scaffolds for the management of Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"215","author":[{"given":"Yash Pal","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Rai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gourav","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gireesh Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7029-1163","authenticated-orcid":false,"given":"Saroj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Srikrishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyan","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113278_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2021.113278_bib2","first-page":"1","article-title":"Drug repurposing for Alzheimer\u2019s disease: in silico and in\u00a0vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors","author":"Kumar","year":"2020","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2021.113278_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11030-018-9878-4","article-title":"A\u00a0review on iron chelators as potential therapeutic agents for the treatment of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"23","author":"Singh","year":"2019","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2021.113278_bib4","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ejmech.2018.02.035","article-title":"Secretase inhibitors for the treatment of Alzheimer\u2019s disease: long road ahead","volume":"148","author":"Kumar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib6","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1039\/D0BM00756K","article-title":"Multifunctional nano-enabled delivery systems in Alzheimer\u2019s disease management","volume":"8","author":"Qian","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejmech.2021.113278_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1745-7254.2008.00752.x","article-title":"Multipotent natural agents to combat Alzheimer\u2019s disease. Functional spectrum and structural features","volume":"29","author":"Ji","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2021.113278_bib8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer\u2019s disease: an appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.ejmech.2021.113278_bib9","volume":"vol. 7","author":"Christensen","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113278_bib10","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.ejmech.2021.113278_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1021\/acschemneuro.7b00457","article-title":"Crafting of neuroprotective octapeptide from taxol-binding pocket of \u03b2-tubulin","volume":"9","author":"Mondal","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1\u03b2 and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients","volume":"202","author":"Blum-Degena","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2021.113278_bib13","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/cr00081a005","article-title":"Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states","volume":"87","author":"Quinn","year":"1987","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.113278_bib14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","article-title":"The history of the cholinergic hypothesis","volume":"221","author":"Contestabile","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2021.113278_bib15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1101\/lm.69204","article-title":"The cholinergic lesion of Alzheimer\u2019s disease: pivotal factor or side show?","volume":"11","author":"Mesulam","year":"2004","journal-title":"Learn. Mem."},{"key":"10.1016\/j.ejmech.2021.113278_bib16","article-title":"A\u00a0review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease","volume":"15","author":"Nordberg","year":"2013","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.ejmech.2021.113278_bib17","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer\u2019s disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2021.113278_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinesterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2021.113278_bib19","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jmedchem.5b01674","article-title":"Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode","volume":"59","author":"Sawatzky","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1017\/S1092852900014164","article-title":"The interplay of neurotransmitters in Alzheimer\u2019s disease","volume":"10","author":"Francis","year":"2005","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ejmech.2021.113278_bib21","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1468-1331.2007.02049.x","article-title":"How long can patients with mild or moderate Alzheimer\u2019s dementia maintain both the cognition and the therapy of cholinesterase inhibitors: a national population-based study","volume":"15","author":"Sun","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ejmech.2021.113278_bib22","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer\u2019s disease","volume":"366","author":"Howard","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113278_bib23","first-page":"391","article-title":"Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer\u2019s disease","volume":"10","author":"Hager","year":"2014","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.ejmech.2021.113278_bib24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2165\/11206380-000000000-00000","article-title":"Rivastigmine transdermal patch: a review of its use in the management of dementia of the Alzheimer\u2019s type","volume":"71","author":"Dhillon","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2021.113278_bib25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113278_bib26","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.1021\/acs.jmedchem.7b00702","article-title":"Donepezil-based central acetylcholinesterase inhibitors by means of a \"Bio-Oxidizable\" prodrug strategy: design, synthesis, and in\u00a0vitro biological evaluation","volume":"60","author":"Peauger","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib27","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib28","doi-asserted-by":"crossref","first-page":"112257","DOI":"10.1016\/j.ejmech.2020.112257","article-title":"Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer\u2019s disease","volume":"198","author":"Singh","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib29","first-page":"1075","article-title":"The neuropathological changes associated with normal brain aging","volume":"11","author":"Hof","year":"1996","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ejmech.2021.113278_bib30","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2021.113278_bib31","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2021.113278_bib32","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1074\/jbc.M113.498246","article-title":"Characterization of intermediate steps in amyloid beta (A\u03b2) production under near-native conditions","volume":"289","author":"Olsson","year":"2014","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-\u03b2 oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2021.113278_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.arr.2012.06.002","article-title":"Viewpoint: crosstalks between neurofibrillary tangles and amyloid plaque formation","volume":"12","author":"Luan","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2021.113278_bib35","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113278_bib36","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"33","author":"Lee","year":"2010","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2021.113278_bib37","first-page":"759","article-title":"Outcomes of Alzheimer\u2019s disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejmech.2021.113278_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00427","article-title":"Involvement of astrocytes in Alzheimer\u2019s disease from a neuroinflammatory and oxidative stress perspective","volume":"10","author":"Gonz\u00e1lez-Reyes","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib39","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","article-title":"beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis","volume":"21","author":"Combs","year":"2001","journal-title":"J.\u00a0Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib40","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.1523\/JNEUROSCI.20-20-07587.2000","article-title":"CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44\/42 mitogen-activated protein kinase","volume":"20","author":"Tan","year":"2000","journal-title":"J.\u00a0Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib41","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1523\/JNEUROSCI.23-05-01605.2003","article-title":"Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway","volume":"23","author":"Li","year":"2003","journal-title":"J.\u00a0Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.yexcr.2004.01.002","article-title":"Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5\/p35 pathway","volume":"295","author":"Quintanilla","year":"2004","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2021.113278_bib43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","article-title":"Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies","volume":"174","author":"Sharma","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2021.113278_bib44","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0166-2236(03)00067-5","article-title":"The metallobiology of Alzheimer\u2019s disease","volume":"26","author":"Bush","year":"2003","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib45","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1038\/s41380-019-0375-7","article-title":"Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology","volume":"25","author":"Ayton","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejmech.2021.113278_bib46","series-title":"Alzheimer\u2019s Disease, Codon Publications Copyright: the Authors.","article-title":"The role of trace metals in Alzheimer\u2019s disease","author":"De Benedictis","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113278_bib47","series-title":"Iron and Ferroptosis as Therapeutic Targets in Alzheimer\u2019s Disease","author":"Gleason","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113278_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","article-title":"The hallmarks of ferroptosis","volume":"3","author":"Dixon","year":"2019","journal-title":"Annu. Rev. Canc Biol."},{"key":"10.1016\/j.ejmech.2021.113278_bib49","first-page":"794","article-title":"Free radicals and antioxidants in human health: current status and future prospects","volume":"52","author":"Devasagayam","year":"2004","journal-title":"J.\u00a0Assoc. Phys. India"},{"key":"10.1016\/j.ejmech.2021.113278_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.agee.2004.10.022","article-title":"Generation and scavenging of reactive oxygen species in chloroplasts: a submolecular approach","volume":"106","author":"Edreva","year":"2005","journal-title":"Agric. Ecosyst. Environ."},{"key":"10.1016\/j.ejmech.2021.113278_bib51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/cells7120274","article-title":"The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases","volume":"7","author":"Kausar","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2021.113278_bib52","first-page":"376","article-title":"Oxidative stress in neurodegenerative diseases","volume":"7","author":"Chen","year":"2012","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2021.113278_bib53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/cam.3.1.7402","article-title":"Oxidative stress in Alzheimer disease","volume":"3","author":"Gella","year":"2009","journal-title":"Cell Adhes. Migrat."},{"key":"10.1016\/j.ejmech.2021.113278_bib54","series-title":"Microbial Diversity in the Genomic Era","first-page":"153","article-title":"Chapter 10 - biochemical strategies to counter nitrosative stress: nanofactories for value-Added products","author":"Alhasawi","year":"2019"},{"key":"10.1016\/j.ejmech.2021.113278_bib55","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00204-019-02538-y","article-title":"Management of oxidative stress and other pathologies in Alzheimer\u2019s disease","volume":"93","author":"Simunkova","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113278_bib56","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1523\/JNEUROSCI.19-06-01959.1999","article-title":"RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer\u2019s disease","volume":"19","author":"Nunomura","year":"1999","journal-title":"J.\u00a0Neurosci. : Off. J. Soc. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-009-0508-1","article-title":"RNA oxidation in Alzheimer disease and related neurodegenerative disorders","volume":"118","author":"Nunomura","year":"2009","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2021.113278_bib58","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1046\/j.1471-4159.1995.65052146.x","article-title":"Brain regional correspondence between Alzheimer\u2019s disease histopathology and biomarkers of protein oxidation","volume":"65","author":"Hensley","year":"1995","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.ejmech.2021.113278_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2017.01.003","article-title":"The pharmacology of tacrine at N-methyl-d-aspartate receptors","volume":"75","author":"Horak","year":"2017","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2021.113278_bib60","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejmech.2019.05.020","article-title":"Multi-target design strategies for the improved treatment of Alzheimer\u2019s disease","volume":"176","author":"Zhang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib61","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.2174\/092986710791111206","article-title":"Tacrine derivatives and Alzheimer\u2019s disease","volume":"17","author":"Tumiatti","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib62","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2021.113278_bib63","doi-asserted-by":"crossref","first-page":"7684","DOI":"10.1021\/acs.jafc.9b02078","article-title":"Protective effect of caffeic acid against Alzheimer\u2019s disease pathogenesis via modulating cerebral insulin signaling, \u03b2-amyloid accumulation, and synaptic plasticity in hyperinsulinemic rats","volume":"67","author":"Chang","year":"2019","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib64","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4103\/1673-5374.230303","article-title":"Use of curcumin in diagnosis, prevention, and treatment of Alzheimer\u2019s disease","volume":"13","author":"Chen","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2021.113278_bib65","first-page":"285","volume":"vol. 16","author":"Hamaguchi","year":"2010"},{"key":"10.1016\/j.ejmech.2021.113278_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21061975","article-title":"Curcumin in health and diseases: Alzheimer\u2019s disease and curcumin analogues, derivatives, and hybrids","volume":"21","author":"Chainoglou","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113278_bib67","series-title":"A\u00a0Promising Candidate for Therapeutic Applications","first-page":"11","author":"Karthikeyan","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113278_bib68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1080\/14756366.2017.1412314","article-title":"Synthesis and bioevaluation of new tacrine-cinnamic acid hybrids as cholinesterase inhibitors against Alzheimer\u2019s disease","volume":"33","author":"Chen","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib69","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/14756366.2016.1256883","article-title":"Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"32","author":"Lan","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib70","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1871527317666180508123050","article-title":"Protective effect of kaempferol on the transgenic Drosophila model of Alzheimer\u2019s disease","volume":"17","author":"Beg","year":"2018","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmech.2021.113278_bib71","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4103\/1673-5374.238714","article-title":"Kaempferol attenuates cognitive deficit via regulating oxidative stress and neuroinflammation in an ovariectomized rat model of sporadic dementia","volume":"13","author":"Kouhestani","year":"2018","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejmech.2021.113278_bib72","first-page":"e1749","volume":"vol. 94","author":"Holland","year":"2020"},{"key":"10.1016\/j.ejmech.2021.113278_bib73","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1111\/bph.13569","article-title":"Butein provides neuroprotective and anti-neuroinflammatory effects through Nrf2\/ARE-dependent haem oxygenase 1 expression by activating the PI3K\/Akt pathway","volume":"173","author":"Lee","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113278_bib74","first-page":"25","article-title":"Simultaneous study of anti-ferroptosis and antioxidant mechanisms of butein and (S)-Butin","author":"Liu","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113278_bib75","first-page":"753","article-title":"Cholinesterase targeting by polyphenols: a therapeutic approach for the treatment of Alzheimer\u2019s disease","volume":"24","author":"Jabir","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113278_bib76","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2174\/1389557515666150522102545","article-title":"Ferulic acid and Alzheimer\u2019s disease: promises and pitfalls","volume":"15","author":"Seyed Fazel","year":"2015","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib77","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1021\/acs.jmedchem.6b01178","article-title":"The antioxidant additive approach for Alzheimer\u2019s disease therapy: new ferulic (lipoic) acid plus melatonin modified tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-like 2 Activators","volume":"59","author":"Benchekroun","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib78","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.btre.2014.09.002","article-title":"Potential applications of ferulic acid from natural sources","volume":"4","author":"Kumar","year":"2014","journal-title":"Biotechnol. Rep."},{"key":"10.1016\/j.ejmech.2021.113278_bib79","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10522-008-9160-8","article-title":"Ferulic acid and its therapeutic potential as a hormetin for age-related diseases","volume":"10","author":"Barone","year":"2009","journal-title":"Biogerontology"},{"key":"10.1016\/j.ejmech.2021.113278_bib80","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3164\/jcbn.40.92","article-title":"Ferulic Acid: therapeutic potential through its antioxidant property","volume":"40","author":"Srinivasan","year":"2007","journal-title":"J.\u00a0Clin. Biochem. Nutr."},{"key":"10.1016\/j.ejmech.2021.113278_bib81","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/09168451.2015.1107463","article-title":"Water-soluble ferulic acid derivatives improve amyloid-\u03b2-induced neuronal cell death and dysmnesia through inhibition of amyloid-\u03b2 aggregation","volume":"80","author":"Kikugawa","year":"2016","journal-title":"Biosc. Biotech. Biochem."},{"key":"10.1016\/j.ejmech.2021.113278_bib82","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1021\/acschemneuro.8b00530","article-title":"Design, synthesis, and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"10","author":"Sang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib83","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.3390\/nu7075246","article-title":"Ferulic acid: a hope for Alzheimer\u2019s disease therapy from plants","volume":"7","author":"Sgarbossa","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2021.113278_bib84","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2741\/2130","article-title":"Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders","volume":"12","author":"Mancuso","year":"2007","journal-title":"Front. Biosci. : J. Vis. Literacy"},{"key":"10.1016\/j.ejmech.2021.113278_bib85","doi-asserted-by":"crossref","first-page":"12411","DOI":"10.3390\/ijms140612411","article-title":"Protein folding and aggregation into amyloid: the interference by natural phenolic compounds","volume":"14","author":"Stefani","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113278_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjp.0704047","article-title":"Protection against beta-amyloid peptide toxicity in\u00a0vivo with long-term administration of ferulic acid","volume":"133","author":"Yan","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113278_bib87","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1039\/C6MD00053C","article-title":"Synthesis and evaluation of donepezil\u2013ferulic acid hybrids as multi-target-directed ligands against Alzheimer\u2019s disease","volume":"7","author":"Xu","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113278_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2016.00160","article-title":"Mechanisms of A\u03b2 clearance and degradation by glial cells","volume":"8","author":"Ries","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib89","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","article-title":"REVIEW: curcumin and Alzheimer\u2019s disease","volume":"16","author":"Hamaguchi","year":"2010","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2021.113278_bib90","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2353\/ajpath.2009.090417","article-title":"Phenolic compounds prevent Alzheimer\u2019s pathology through different effects on the amyloid-beta aggregation pathway","volume":"175","author":"Hamaguchi","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejmech.2021.113278_bib91","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.bbagen.2006.03.022","article-title":"Esterification of ferulic acid with polyols using a ferulic acid esterase from Aspergillus Niger","volume":"1760","author":"Tsuchiyama","year":"2006","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.ejmech.2021.113278_bib92","doi-asserted-by":"crossref","first-page":"103413","DOI":"10.1016\/j.bioorg.2019.103413","article-title":"Design, synthesis and evaluation of novel ferulic acid derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"94","author":"Lan","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib93","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ejmech.2016.12.003","article-title":"Novel ferulic amide derivatives with tertiary amine side chain as acetylcholinesterase and butyrylcholinesterase inhibitors: the influence of carbon spacer length, alkylamine and aromatic group","volume":"126","author":"Liu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib94","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0891-5849(95)02227-9","article-title":"Structure-antioxidant activity relationships of flavonoids and phenolic acids","volume":"20","author":"Rice-Evans","year":"1996","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113278_bib95","first-page":"355","volume":"vol. 79","author":"Kroon","year":"1999"},{"key":"10.1016\/j.ejmech.2021.113278_bib96","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1080\/09168451.2017.1336925","article-title":"Ferulic acid and its water-soluble derivatives inhibit nitric oxide production and inducible nitric oxide synthase expression in rat primary astrocytes","volume":"81","author":"Kikugawa","year":"2017","journal-title":"Biosc. Biotech. Biochem."},{"key":"10.1016\/j.ejmech.2021.113278_bib97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejphar.2016.04.047","article-title":"Protective effects of a dimeric derivative of ferulic acid in animal models of Alzheimer\u2019s disease","volume":"782","author":"Jung","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113278_bib98","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phymed.2010.02.002","article-title":"Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy","volume":"17","author":"Panossian","year":"2010","journal-title":"Phytomedicine : Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.ejmech.2021.113278_bib99","first-page":"3","article-title":"Effects of alcohol aqueous extract from Rhodiola rosea L. roots on learning and memory","volume":"12","author":"Petkov","year":"1986","journal-title":"Acta Physiol. Pharmacol. Bulg."},{"key":"10.1016\/j.ejmech.2021.113278_bib100","first-page":"235","article-title":"The effectiveness and efficacy of Rhodiola rosea L.: a systematic review of randomized clinical trials, Phytomedicine","volume":"18","author":"Hung","year":"2011","journal-title":"Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.ejmech.2021.113278_bib101","volume":"vol. 4","author":"Michels","year":"2018"},{"key":"10.1016\/j.ejmech.2021.113278_bib102","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ejmech.2017.02.043","article-title":"Design, synthesis and evaluation of novel feruloyl-donepezil hybrids as potential multitarget drugs for the treatment of Alzheimer\u2019s disease","volume":"130","author":"Dias","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib103","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ejmech.2017.02.039","article-title":"Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"130","author":"Sang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib104","first-page":"15","volume":"vol. 7","author":"Benchekroun","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113278_bib105","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/j.bmcl.2008.03.073","article-title":"Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates","volume":"18","author":"Fang","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113278_bib106","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer\u2019s disease","volume":"271","author":"Watkins","year":"1994","journal-title":"Jama"},{"key":"10.1016\/j.ejmech.2021.113278_bib107","first-page":"523","volume":"vol. 10","author":"Benchekroun","year":"2015"},{"key":"10.1016\/j.ejmech.2021.113278_bib108","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bmcl.2014.12.084","article-title":"Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD","volume":"25","author":"Digiacomo","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113278_bib109","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/j.bmcl.2012.08.036","article-title":"Design, synthesis and pharmacological evaluation of novel tacrine\u2013caffeic acid hybrids as multi-targeted compounds against Alzheimer\u2019s disease","volume":"22","author":"Chao","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113278_bib110","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1039\/C5MD00236B","article-title":"Design, synthesis and bioevaluation of tacrine hybrids with cinnamate and cinnamylidene acetate derivatives as potential anti-Alzheimer drugs","volume":"6","author":"Quintanova","year":"2015","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2021.113278_bib111","first-page":"21","article-title":"Design, synthesis and evaluation of novel tacrine-ferulic acid hybrids as multifunctional drug candidates against Alzheimer\u2019s disease","author":"Fu","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113278_bib112","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1021\/jm300106z","article-title":"Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors","volume":"55","author":"Chen","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib113","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bmcl.2014.12.084","article-title":"Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD","volume":"25","author":"Digiacomo","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113278_bib114","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ejmech.2016.09.052","article-title":"Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer\u2019s disease","volume":"125","author":"Chen","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib115","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bmc.2017.12.042","article-title":"A\u00a0review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer\u2019s disease","volume":"26","author":"Zhang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib116","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ejmech.2016.05.055","article-title":"New cinnamic \u2013 N-benzylpiperidine and cinnamic \u2013 N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties","volume":"121","author":"Estrada","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib117","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2019.07.011","article-title":"Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-\u03b2 peptide in Alzheimer\u2019s disease","volume":"180","author":"Rosini","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib118","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","article-title":"Glutamate receptor ion channels: structure, regulation, and function","volume":"62","author":"Traynelis","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2021.113278_bib119","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40478-018-0611-4","article-title":"NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (A\u03b2) overexpressing mice","volume":"6","author":"M\u00fcller","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejmech.2021.113278_bib120","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways","volume":"5","author":"Hardingham","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2021.113278_bib121","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1038\/srep14781","article-title":"Pharmacologically targeted NMDA receptor antagonism by NitroMemantine for cerebrovascular disease","volume":"5","author":"Takahashi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2021.113278_bib122","doi-asserted-by":"crossref","first-page":"112265","DOI":"10.1016\/j.ejmech.2020.112265","article-title":"Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer\u2019s disease","volume":"194","author":"Sang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib123","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.bmc.2016.01.010","article-title":"Ferulic acid\u2013carbazole hybrid compounds: combination of cholinesterase inhibition, antioxidant and neuroprotection as multifunctional anti-Alzheimer agents","volume":"24","author":"Fang","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib124","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/j.bmcl.2016.03.086","article-title":"Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Pan","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113278_bib125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejmech.2017.07.077","article-title":"Novel cinnamamide-dibenzylamine hybrids: potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer\u2019s disease","volume":"139","author":"Wang","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib126","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2017.07.058","article-title":"Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer\u2019s disease","volume":"139","author":"De Simone","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib127","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bioorg.2018.12.029","article-title":"Synthesis, antioxidant and A\u03b2 anti-aggregation properties of new ferulic, caffeic and lipoic acid derivatives obtained by the Ugi four-component reaction","volume":"85","author":"Benchekroun","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib128","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/molecules21040440","article-title":"Novel selective butyrylcholinesterase inhibitors incorporating antioxidant functionalities as potential bimodal therapeutics for Alzheimer\u2019s disease","volume":"21","author":"Jones","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113278_bib129","first-page":"25","article-title":"Exploring the multi-target performance of mitochondriotropic antioxidants against the pivotal Alzheimer\u2019s disease pathophysiological hallmarks","author":"Benfeito","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113278_bib130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/14756366.2010.529806","article-title":"Bifunctional phenolic-choline conjugates as anti-oxidants and acetylcholinesterase inhibitors","volume":"26","author":"Sebest\u00edk","year":"2011","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib131","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1021\/acs.bioconjchem.8b00151","article-title":"Development of a PEGylated-based platform for efficient delivery of dietary antioxidants across the blood-brain barrier","volume":"29","author":"Fernandes","year":"2018","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib132","doi-asserted-by":"crossref","first-page":"9646","DOI":"10.1039\/C9OB01875A","article-title":"Bioisosteric OH- to SH-replacement changes the antioxidant profile of ferulic acid","volume":"17","author":"Chavarria","year":"2019","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib133","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.foodchem.2018.02.007","article-title":"Microencapsulation of caffeic acid phenethyl ester and caffeic acid phenethyl amide by inclusion in hydroxypropyl-\u03b2-cyclodextrin","volume":"254","author":"Garrido","year":"2018","journal-title":"Food Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib134","doi-asserted-by":"crossref","first-page":"103506","DOI":"10.1016\/j.bioorg.2019.103506","article-title":"Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer\u2019s disease","volume":"95","author":"Tripathi","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib135","doi-asserted-by":"crossref","first-page":"101378","DOI":"10.1016\/j.redox.2019.101378","article-title":"7-O-Esters of taxifolin with pronounced and overadditive effects in neuroprotection, anti-neuroinflammation, and amelioration of short-term memory impairment in\u00a0vivo","volume":"29","author":"Gunesch","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2021.113278_bib136","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1016\/j.bmc.2011.09.040","article-title":"Benzenediol-berberine hybrids: multifunctional agents for Alzheimer\u2019s disease","volume":"19","author":"Jiang","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib137","first-page":"886","article-title":"Primary prevention of Alzheimer\u2019s disease: is it an attainable goal?","volume":"29","author":"Han","year":"2014","journal-title":"J.\u00a0Kor. Med. Sci."},{"key":"10.1016\/j.ejmech.2021.113278_bib138","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1016\/j.bmcl.2007.04.079","article-title":"Ferulic acid and benzothiazole dimer derivatives with high binding affinity to \u03b2-amyloid fibrils","volume":"17","author":"Byeon","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113278_bib139","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13065-018-0481-7","article-title":"Hybrid caffeic acid derivatives as monoamine oxidases inhibitors: synthesis, radical scavenging activity, molecular docking studies and in silico ADMET analysis","volume":"12","author":"Dhiman","year":"2018","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.ejmech.2021.113278_bib140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ardp.201500317","article-title":"Monoamine oxidase inhibitory activity of ferulic acid amides: curcumin-based design and synthesis","volume":"349","author":"Badavath","year":"2016","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2021.113278_bib141","doi-asserted-by":"crossref","first-page":"5162","DOI":"10.1016\/j.ejmech.2011.08.036","article-title":"Monoamine oxidase inhibition by selected anilide derivatives","volume":"46","author":"Legoabe","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113278_bib142","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1248\/cpb.c17-00416","article-title":"Synthesis of amide and ester derivatives of cinnamic acid and its analogs: evaluation of their free radical scavenging and monoamine oxidase and cholinesterase inhibitory activities","volume":"65","author":"Takao","year":"2017","journal-title":"Chem. Pharm. Bull."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421001276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:25:16Z","timestamp":1759328716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421001276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":142,"alternative-id":["S0223523421001276"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113278","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review on ferulic acid and analogs based scaffolds for the management of Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113278"}}